Aurinia Pharmaceuticals Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2019 | $30.0K | $-14.9M | $-14.1M |
| Jun 2019 | $29.0K | $-17.1M | $-16.4M |
| Sep 2019 | $230.0K | $-24.1M | $-23.5M |
| Dec 2019 | $29.0K | $-34.8M | $-34.5M |
| Mar 2020 | $30.0K | $-27.1M | $-25.9M |
| Jun 2020 | $29.0K | $-26.9M | $-26.5M |
| Sep 2020 | $29.0K | $-42.3M | $-42.1M |
| Dec 2020 | $50.0M | $-8.1M | $-8.1M |
| Mar 2021 | $914.0K | $-50.5M | $-50.4M |
| Jun 2021 | $6.6M | $-47.1M | $-47.0M |
| Sep 2021 | $14.7M | $-50.4M | $-50.3M |
| Dec 2021 | $23.4M | $-32.7M | $-33.3M |
| Mar 2022 | $21.6M | $-37.9M | $-37.6M |
| Jun 2022 | $28.2M | $-36.0M | $-35.5M |
| Sep 2022 | $55.8M | $-9.5M | $-9.0M |
| Dec 2022 | $28.4M | $-28.1M | $-26.0M |
| Mar 2023 | $34.4M | $-29.6M | $-26.2M |
| Jun 2023 | $41.5M | $-16.2M | $-11.5M |
| Sep 2023 | $54.5M | $-16.3M | $-13.4M |
| Dec 2023 | $45.1M | $-29.7M | $-26.9M |
| Mar 2024 | $50.3M | $-13.3M | $-10.7M |
| Jun 2024 | $57.2M | $-1.5M | $722.0K |
| Sep 2024 | $67.8M | $11.7M | $14.4M |
| Dec 2024 | $59.9M | $-1.7M | $1.4M |
| Mar 2025 | $62.5M | $21.8M | $23.3M |
| Jun 2025 | $70.0M | $20.1M | $21.5M |
| Sep 2025 | $73.5M | $29.7M | $31.6M |
| Dec 2025 | $77.1M | $33.2M | $210.8M |
| Mar 2026 | $77.7M | $41.4M | $34.4M |
| Jun 2026 | $83.2M | $46.3M | $37.4M |